Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 4, 2024
Use of coronary physiology to guide revascularization in clinical practice: results of the F(FR)<sup>2</sup> registry
J Michael Altstidl, Stephan Achenbach, Johannes Feyrer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
August 29, 2013
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group
Franz X Kleber, Harald Rittger, Klaus Bonaventura, et al.
Herz
|
June 26, 2025
[Palliative care and change in treatment goals for heart failure in the outpatient sector : A survey among office-based physicians in Germany on the current state of healthcare provision]
Moritz Blum, Mark Weber-Krüger, Hashim Abdul-Khaliq, et al.
Lancet (London, England)
|
February 24, 2012
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial
Holger Thiele, Jochen Wöhrle, Rainer Hambrecht, et al.
European Journal of Preventive Cardiology
|
June 2, 2022
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry
Mathieu Kerneis, Francesco Cosentino, Roberto Ferrari, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 4, 2015
[Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology]
Oliver Vonend, Michael Böhm, Siegfried Eckert, et al.
Journal of the American College of Cardiology
|
July 16, 2013
Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial
Steffen Desch, Jochen Wöhrle, Rainer Hambrecht, et al.
JACC. Cardiovascular Interventions
|
October 19, 2015
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter)
Harald Rittger, Matthias Waliszewski, Johannes Brachmann, et al.
BMC Cardiovascular Disorders
|
April 2, 2023
Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial
Sylvia Otto, Victor Alfonso Jiménez Díaz, Daniel Weilenmann, et al.
Journal of the American College of Cardiology
|
March 6, 2012
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study
Harald Rittger, Johannes Brachmann, Anil-M Sinha, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 4, 2024
Use of coronary physiology to guide revascularization in clinical practice: results of the F(FR)<sup>2</sup> registry
J Michael Altstidl, Stephan Achenbach, Johannes Feyrer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
August 29, 2013
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group
Franz X Kleber, Harald Rittger, Klaus Bonaventura, et al.
Herz
|
June 26, 2025
[Palliative care and change in treatment goals for heart failure in the outpatient sector : A survey among office-based physicians in Germany on the current state of healthcare provision]
Moritz Blum, Mark Weber-Krüger, Hashim Abdul-Khaliq, et al.
Lancet (London, England)
|
February 24, 2012
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial
Holger Thiele, Jochen Wöhrle, Rainer Hambrecht, et al.
European Journal of Preventive Cardiology
|
June 2, 2022
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry
Mathieu Kerneis, Francesco Cosentino, Roberto Ferrari, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 4, 2015
[Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology]
Oliver Vonend, Michael Böhm, Siegfried Eckert, et al.
Journal of the American College of Cardiology
|
July 16, 2013
Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial
Steffen Desch, Jochen Wöhrle, Rainer Hambrecht, et al.
JACC. Cardiovascular Interventions
|
October 19, 2015
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter)
Harald Rittger, Matthias Waliszewski, Johannes Brachmann, et al.
BMC Cardiovascular Disorders
|
April 2, 2023
Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial
Sylvia Otto, Victor Alfonso Jiménez Díaz, Daniel Weilenmann, et al.
Journal of the American College of Cardiology
|
March 6, 2012
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study
Harald Rittger, Johannes Brachmann, Anil-M Sinha, et al.
Page
of 7